Investor Relations

BG Medicine is a privately held company founded in 2000 by Flagship Ventures.  Since its inception it has received over $50 Million in equity funding from its institutional investors Flagship Ventures and Gilde Investment Management and from strategic investors, including Royal Philips and Waters Corporation.
For investment inquiries contact: Stacie Rader, Corporate Communications
srader@bg-medicine.com Tel: 781-890-1199